Literature DB >> 2138602

In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.

C Watanakunakorn1.   

Abstract

Nineteen strains of Staphylococcus aureus (five penicillin-susceptible and methicillin-susceptible, four methicillin-susceptible and penicillin-resistant, and ten methicillin-resistant) were serially subcultured in broth media containing a subinhibitory concentration (half the MIC) of either teicoplanin or vancomycin. The MIC of the antibiotic was again measured after five passages in antibiotic-containing broth. The experiment was terminated after 25 passages. After passage fifteen strains exhibited an eight-fold or greater increase in MIC of teicoplanin. On the other hand, only two strains exhibited even an unstable four-fold increase in MIC of vancomycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138602     DOI: 10.1093/jac/25.1.69

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

1.  Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.

Authors:  J R Aeschlimann; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

3.  Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.

Authors:  G Vedel; M Leruez; F Lémann; E Hraoui; D Ratovohery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

4.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus.

Authors:  G P Voorn; J Thompson; W H Goessens; W C Schmal-Bauer; P H Broeders; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

6.  Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  J R Aeschlimann; G P Allen; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 8.  Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  R N Brogden; D H Peters
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

Review 9.  Teicoplanin in perspective. A critical comparison with vancomycin.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1991-08-23

10.  In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.

Authors:  Lorenzo Drago; Elena De Vecchi; Lucia Nicola; Maria Rita Gismondo
Journal:  BMC Infect Dis       Date:  2007-09-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.